Home > Journals > Minerva Stomatologica > Past Issues > Minerva Stomatologica 2003 April;52(4) > Minerva Stomatologica 2003 April;52(4):187-92

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

CASE REPORT   

Minerva Stomatologica 2003 April;52(4):187-92

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: Italian

Mucous-cutaneous bullous pemphigoid induced by valsartan. A clinical case

Femiano F.


PDF


In the presence of immune-mediated vesiculo-bullous diseases, the oral pathologist should focus his attention not only on the diagnosis and treatment of the case, but should particularly investigate the state of genetic predisposition in relation to the HLA haplotype structure and look for the possible trigger factors for the disease. The detection of the trigger may guarantee a faster cure with a minimum therapeutic contribution. In the search for triggering factors, the drugs that are traditionally incriminated such as ACE inhibitors, Fans, antibiotics (penicillin and penicillamine), substances with -SH groups, tranquillisers, are not always involved in inducing vesiculo-bullous diseases. Substances considered innocuous are often to blame. We present a case of mucous-cutaneous bullous pemphigoid induced by an anti-hypertensive of the sartan group, valsartan.

top of page